Literature DB >> 8370682

Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation.

J F McLeod1, L Kovács, M B Gaskill, S Rittig, G S Bradley, G L Robertson.   

Abstract

We studied the pathophysiology, natural history, and genetic basis of familial neurohypophyseal diabetes insipidus (FNDI) in a caucasian kindred. Twelve members had polyuria and a deficiency of plasma vasopressin (AVP), which progressed in severity over time. Another had normal urine volumes and plasma AVP when first tested at age 3 yr, but developed severe FNDI a year later. For unknown reasons, one man had a normal urine volume despite severe AVP deficiency and a history of polyuria in the past. When the AVP-neurophysin-II gene was amplified and sequenced, exon 2/3 was normal, but 7 of 12 clones of exon 1 contained a base substitution (G-->A) predicting a substitution of threonine for alanine at the -1 position of the signal peptide. Restriction analysis found the mutation in all 14 affected members, but in none of the 41 controls or 19 adult members with normal urine volumes and plasma or urinary AVP (lod score = 5.7). The mutation was also found in 2 infants in whom AVP was normal when tested at 6 and 9 months of age. We hypothesize that a mutation in exon 1 of the AVP-neurophysin-II gene causes FNDI in this kindred by making an abnormally processed precursor that gradually destroys vasopressinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370682     DOI: 10.1210/jcem.77.3.8370682

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Familial forms of diabetes insipidus: clinical and molecular characteristics.

Authors:  Muriel Babey; Peter Kopp; Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

2.  Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum.

Authors:  M Ito; J L Jameson; M Ito
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

Review 3.  Diabetes insipidus in children: pathophysiology, diagnosis and management.

Authors:  Tim Cheetham; Peter H Baylis
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Two novel mutations in seven Czech and Slovak kindreds with familial neurohypophyseal diabetes insipidus-benefit of genetic testing.

Authors:  Gabriela Hrčková; Viktor Jankó; Jitka Kytnarová; Michaela Čižmárová; Markéta Tesařová; Ľudmila Košťálová; Daniela Virgová; Tomáš Dallos; Václav Hána; Jan Lebl; Jiří Zeman; László Kovács
Journal:  Eur J Pediatr       Date:  2016-08-18       Impact factor: 3.183

5.  A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons.

Authors:  Theron A Russell; Masafumi Ito; Mika Ito; Richard N Yu; Fred A Martinson; Jeffrey Weiss; J Larry Jameson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus.

Authors:  S Rittig; G L Robertson; C Siggaard; L Kovács; N Gregersen; J Nyborg; E B Pedersen
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

7.  Utility of genetic testing in suspected familial cranial diabetes insipidus.

Authors:  Ramesh Srinivasan; Stephen Ball; Martin Ward-Platt; David Bourn; Ciaron McAnulty; Tim Cheetham
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2013-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.